Page 43 - Cardiac testing for coronary artery disease in potential kidney transplant recipients
P. 43

Brennan 1997
                 Clinical features and settings  Clinical features
                                                  • Patients with ESKD at risk of CAD who presented for kidney transplant cardiac
                                                evaluation
                                                Setting
                                                  • Washington University and Barnes-Jewish Hospital, St. Louis, Missouri, USA

                 Participants                     • Number: 47
                                                  • DM: 56%
                                                  • Hypertension: 90%
                                                  • Sex: 45% male
                                                  • Mean age: 51 years
                                                  • History of smoking: 61%
                                                  • Hypercholesterolaemia: 15%
                                                  • Coronary heart failure: 2%
                                                  • Clinical evidence CAD: 21%
                 Study design                   Cohort study

                 Target condition and reference standard(s) Coronary artery stenosis measured by coronary angiography
                                                  • The criterion for positive test results was ≥ 50% reduction in cross sectional area.

                 Index and comparator tests     DSE
                                                  • Two-dimensional echocardiography as part of pretransplant evaluation. Graded
                                                infusions of dobutamine were administered (5 to 40 mg/kg/min) until the maximum
                                                predicted heart rate was achieved. If needed, IV atropine (0.4 to 2.0 mg) was given to
                                                increase heart rate to ~85% of the maximum predicted heart rate. The test was
                                                terminated if patients developed: significant arrhythmia, severe hypertension or
                                                hypotension, or had new or worsening baseline segmental wall motion abnormalities in
                                                ≥ 2 major coronary perfusion regions. Segmental wall motion was scored according to
                                                American Society of Echocardiography recommendations, using lh-segment model.
                                                Each segment was graded using a semi-quantitative scoring system (normal or
                                                hyperdynamic (1); hypokinesis (2); akinesis (3); dyskinesis (4)). The wall motion score
                                                index was derived as an average of the 16 segments. All studies were reviewed
                                                independently by 2 experienced echocardiographers who were blinded to the clinical
                                                data.
                 Follow-up                      Follow-up (range 3 to 64 months) data were obtained for all 47 participants

                 Notes                          Of the 47 patients who underwent DSE, all 5 patients who tested positive received
                                                coronary angiography. Seven other patients who had negative DSE received coronary
                                                angiography. The decision about providing coronary angiography for those who were
                                                index test negative was not made on grounds of clinical or high pre-test suspicion (author
                                                correspondence)

                 Table of Methodological Quality

                 Item                           Authors’ judgement             Description





                Cardiac testing for coronary artery disease in potential kidney transplant recipients (Review)  41
                Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
   38   39   40   41   42   43   44   45   46   47   48